{"id":950856,"date":"2026-04-13T11:37:38","date_gmt":"2026-04-13T15:37:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\/"},"modified":"2026-04-13T11:37:38","modified_gmt":"2026-04-13T15:37:38","slug":"lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\/","title":{"rendered":"Lowey Dannenberg Notifies ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ: IBRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, April  13, 2026  (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ: IBRX) for violations of the federal securities laws on behalf of investors who purchased or acquired ImmunityBio securities between January 19, 2026 and March 24, 2026, inclusive (the \u201cClass Period\u201d).<\/p>\n<p align=\"justify\">On March 26, 2026, a complaint was filed against the Company and one of its current officer, alleging that throughout the Class Period, Defendants misrepresented and failed to disclose that: (1) Defendant Soon-Shion materially overstated Anktiva\u2019s capabilities; and (2) as a result, Defendants\u2019 statements about ImmunityBio\u2019s business, operations, and prospects were materially false and misleading and\/or lacked a reasonable basis at all relevant times.<\/p>\n<p align=\"justify\">When investors learned the truth, ImmunityBio\u2019s common stock declined precipitously, injuring investors.<\/p>\n<p align=\"justify\">If you suffered a loss of more than $100,000 in ImmunityBio\u2019s common stock, and wish to participate, or learn more about your eligibility, please contact our attorneys Andrea Farah (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zo4nCoN-lEz5USw0XqQ0PlrfcU4MpRSjv6jWNfM5q88iPrDD2CJpO7a1O-YmFqIMl5oFpsoM2ZBmGRxD4mn49gURPbkF1lrKCo0Luh3K5l8=\" rel=\"nofollow\" target=\"_blank\">afarah@lowey.com<\/a>) at (914)733-7256 or Vincent R. Cappucci Jr. (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OV3O88NhbbSq2vJ07NYSdAWBtMqEhrt0URdgjiYLNSWTMDtuTQNBr6srgCxuuxg4vYe--vCJM_rc08H_IbF-4JlVp5vlQx6e0-i_REwMNK8=\" rel=\"nofollow\" target=\"_blank\">vcappucci@lowey.com<\/a>) at (914)733-7278.<\/p>\n<p align=\"justify\">Any investor who wishes to serve as Lead Plaintiff must act before <strong>May 26, 2026<\/strong>.<\/p>\n<p align=\"justify\">\n        <strong>About Lowey Dannenberg<\/strong>\n      <\/p>\n<p align=\"justify\">Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has recovered billions of dollars on behalf of its clients.<\/p>\n<p align=\"justify\">\n        <strong>Contact<\/strong>:<\/p>\n<p>Lowey Dannenberg P.C.<br \/>44 South Broadway, Suite 1100<br \/>White Plains, NY 10601<br \/>Tel: (914) 733-7234<br \/>Email: afarah@lowey.com<\/p>\n<p>\n        <strong>SOURCE<\/strong>: Lowey Dannenberg P.C.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4ODU4OSM3NTMyMjcxIzIxOTQ1MzQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MzRmY2U2ZjUtY2Q4ZS00ODVmLWI4YzUtY2U2MTY3NTAwMTk0LTEyMDYwODctMjAyNi0wNC0xMy1lbg==\/tiny\/Lowey-Dannenberg-P-C-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ: IBRX) for violations of the federal securities laws on behalf of investors who purchased or acquired ImmunityBio securities between January 19, 2026 and March 24, 2026, inclusive (the \u201cClass Period\u201d). On March 26, 2026, a complaint was filed against the Company and one of its current officer, alleging that throughout the Class Period, Defendants misrepresented and failed to disclose that: (1) Defendant Soon-Shion materially overstated Anktiva\u2019s capabilities; and (2) as a result, Defendants\u2019 statements about ImmunityBio\u2019s business, operations, and prospects were materially &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lowey Dannenberg Notifies ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ: IBRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-950856","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lowey Dannenberg Notifies ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ: IBRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lowey Dannenberg Notifies ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ: IBRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ: IBRX) for violations of the federal securities laws on behalf of investors who purchased or acquired ImmunityBio securities between January 19, 2026 and March 24, 2026, inclusive (the \u201cClass Period\u201d). On March 26, 2026, a complaint was filed against the Company and one of its current officer, alleging that throughout the Class Period, Defendants misrepresented and failed to disclose that: (1) Defendant Soon-Shion materially overstated Anktiva\u2019s capabilities; and (2) as a result, Defendants\u2019 statements about ImmunityBio\u2019s business, operations, and prospects were materially &hellip; Continue reading &quot;Lowey Dannenberg Notifies ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ: IBRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-13T15:37:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4ODU4OSM3NTMyMjcxIzIxOTQ1MzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lowey Dannenberg Notifies ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ: IBRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm\",\"datePublished\":\"2026-04-13T15:37:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\\\/\"},\"wordCount\":299,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4ODU4OSM3NTMyMjcxIzIxOTQ1MzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\\\/\",\"name\":\"Lowey Dannenberg Notifies ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ: IBRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4ODU4OSM3NTMyMjcxIzIxOTQ1MzQ=\",\"datePublished\":\"2026-04-13T15:37:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4ODU4OSM3NTMyMjcxIzIxOTQ1MzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4ODU4OSM3NTMyMjcxIzIxOTQ1MzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lowey Dannenberg Notifies ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ: IBRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lowey Dannenberg Notifies ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ: IBRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\/","og_locale":"en_US","og_type":"article","og_title":"Lowey Dannenberg Notifies ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ: IBRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm - Market Newsdesk","og_description":"NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ: IBRX) for violations of the federal securities laws on behalf of investors who purchased or acquired ImmunityBio securities between January 19, 2026 and March 24, 2026, inclusive (the \u201cClass Period\u201d). On March 26, 2026, a complaint was filed against the Company and one of its current officer, alleging that throughout the Class Period, Defendants misrepresented and failed to disclose that: (1) Defendant Soon-Shion materially overstated Anktiva\u2019s capabilities; and (2) as a result, Defendants\u2019 statements about ImmunityBio\u2019s business, operations, and prospects were materially &hellip; Continue reading \"Lowey Dannenberg Notifies ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ: IBRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-13T15:37:38+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4ODU4OSM3NTMyMjcxIzIxOTQ1MzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lowey Dannenberg Notifies ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ: IBRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm","datePublished":"2026-04-13T15:37:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\/"},"wordCount":299,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4ODU4OSM3NTMyMjcxIzIxOTQ1MzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\/","name":"Lowey Dannenberg Notifies ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ: IBRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4ODU4OSM3NTMyMjcxIzIxOTQ1MzQ=","datePublished":"2026-04-13T15:37:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4ODU4OSM3NTMyMjcxIzIxOTQ1MzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4ODU4OSM3NTMyMjcxIzIxOTQ1MzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-immunitybio-inc-immunitybio-or-the-company-nasdaq-ibrx-investors-of-securities-class-action-lawsuit-and-encourages-investors-with-m\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lowey Dannenberg Notifies ImmunityBio, Inc. (\u201cImmunityBio\u201d or the \u201cCompany\u201d) (NASDAQ: IBRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950856","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=950856"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950856\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=950856"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=950856"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=950856"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}